The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 117:401-408, November 1960
doi: 10.1176/appi.ajp.117.5.401
© 1960 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by FROHMAN, C.
* Articles by GOTTLIEB, J. S.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by FROHMAN, C.
* Articles by GOTTLIEB, J. S.

STEPS TOWARD THE ISOLATION OF A SERUM FACTOR IN SCHIZOPHRENIA

CHARLES FROHMAN PH.D., ELLIOT D. LUBY M.D., GARFIELD TOURNEY M.D., PETER G. S. BECKETT M.D., , and JACQUES S. GOTTLIEB M.D.1

1 Lafayette Clinic, Detroit, Mich. and Wayne State University, College of Medicine.

1. The steps in the separation of a factor in the serum of schizophrenic patients have been described.

2. This factor has a significant effect on metabolism as measured by lactate/pyruvate ratios in the chicken erythrocyte and the stimulation of energy production by forcing glucose through the Emden-Meyerhof scheme, rather than the hexosemonophosphate shunt.

3. This factor is readily affected by pH and temperature, remaining relatively stable between pH 6 and 9 at 4° C. It is probable that this is an alpha globulin or a prosthetic group attached to an alpha globulin.

4. The significance of this factor for the schizophrenic illness has not yet been clarified. This may be a substance normally present in the serum of all individuals, but quantitatively elevated in the schizophrenic because of excessive production or its failure to be metabolized or detoxified. On the other hand, this may be a qualitatively abnormal substance characteristic of schizophrenia.

5. The possible relationship of this factor to other reported toxic factors in schizophrenia has been discussed.

6. Further biochemical studies are in progress to identify the subject, as well as behavioral studies to ascertain its relationship to the production of disturbances in overt behavior.







Get information about faster international access.

Privacy Policy

Copyright © 1960 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org